ICH Guideline S1B(R1) on Testing for Carcinogenicity of Pharmaceuticals

10 October 2022 — EMA published the ICH guideline S1B1(R1) – Step 5.

This document provides guidance on approaches for evaluating the carcinogenic potential of pharmaceuticals.

Read the pdf 
Copyright Widler & Schiemann AG 2022. All Rights Reserved. /